Edit
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Congestive Heart Failure Drugs Market to reach USD 18.30 billion by the end of 2029

Global Congestive Heart Failure Drugs Market Size study & Forecast, by Type (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Analysis, 2022-2029

Product Code: HLSDT-59892318
Publish Date: 29-01-2023
Page: 200

Global Congestive Heart Failure Drugs Market is valued at approximately USD 6.15 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 14.60% over the forecast period 2022-2029. Congestive heart failure (CHF) is a chronic health condition that reduces the pumping of blood in the heart and impacts the ability of the heart muscle. The CHF drugs are specially designed drugs that are used to cure this health problem and aid in increasing the ability of the heart to pump blood effectively. Factors such as the increasing geriatric population, rising product approvals, coupled with growing healthcare expenditure are reinforcing the market demand around the world.

The rising incidences of Congestive Heart Failure (CHF) is a major concern that leads to high morbidity and mortality rate. The Global Health Data Exchange registry reported that the prevalence of congestive heart failure disease was estimated to account for approximately around 64.34 million cases globally, and in the U.S., the incidences were recorded with 5.5 million in 2022. Therefore, the growing cases of CHF are acting as a catalyzing factor for market growth. In addition, the growing R&D for drug development, as well as the strong clinical drugs pipeline are offering various lucrative opportunities over the forecasting years. However, the availability of generic and off-label drugs in the market and poor reimbursement scenarios in developing countries are challenging the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Congestive Heart Failure Drugs Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the rise in patient awareness, along with the rising government initiatives and implementation of several policies. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the increasing prevalence of congestive heart failure, as well as rising healthcare expenditure in the regional market space.

Major market players included in this report are:
Bayer AG
Novartis AG
Merck & Co., Inc.
AstraZeneca
Bristol-Myers Squibb Company
Amgen Inc.
Boehringer Ingelheim International GmbH
Pfizer, Inc.
Johnson & Johnson Services, Inc.
Otsuka Pharmaceutical Co., Ltd.

Recent Developments in the Market:
 In February 2021, AstraZeneca declared the successful regulatory approval of Forxiga in China. The product has already received approval in the U.S., Europe, and Japan, which indicates heart failure with or without type-2 diabetes in adults.

Global Congestive Heart Failure Drugs Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Type offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

ACE Inhibitors
Angiotensin 2 Receptor Blockers
Beta Blockers
Diuretics
Aldosterone Antagonists
Inotropes
Others

By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Congestive Heart Failure Drugs Market, by Region, 2019-2029 (USD Billion)
1.2.2. Congestive Heart Failure Drugs Market, by Type, 2019-2029 (USD Billion)
1.2.3. Congestive Heart Failure Drugs Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Congestive Heart Failure Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Congestive Heart Failure Drugs Market Dynamics
3.1. Congestive Heart Failure Drugs Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising incidences of Congestive heart failure (CHF)
3.1.1.2. Increasing product approvals
3.1.2. Market Challenges
3.1.2.1. Availability of generic and off-label drugs in the market
3.1.2.2. Poor reimbursement scenarios in developing countries
3.1.3. Market Opportunities
3.1.3.1. Growing R&D for drug development
3.1.3.2. Strong clinical drugs pipeline
Chapter 4. Global Congestive Heart Failure Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Congestive Heart Failure Drugs Market, by Type
6.1. Market Snapshot
6.2. Global Congestive Heart Failure Drugs Market by Type, Performance – Potential Analysis
6.3. Global Congestive Heart Failure Drugs Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Congestive Heart Failure Drugs Market, Sub Segment Analysis
6.4.1. ACE Inhibitors
6.4.2. Angiotensin 2 Receptor Blockers
6.4.3. Beta Blockers
6.4.4. Diuretics
6.4.5. Aldosterone Antagonists
6.4.6. Inotropes
6.4.7. Others
Chapter 7. Global Congestive Heart Failure Drugs Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Congestive Heart Failure Drugs Market by Distribution Channel, Performance – Potential Analysis
7.3. Global Congestive Heart Failure Drugs Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
7.4. Congestive Heart Failure Drugs Market, Sub Segment Analysis
7.4.1. Hospital Pharmacies
7.4.2. Retail Pharmacies
7.4.3. Online Pharmacies
Chapter 8. Global Congestive Heart Failure Drugs Market, Regional Analysis
8.1. Congestive Heart Failure Drugs Market, Regional Market Snapshot
8.2. North America Congestive Heart Failure Drugs Market
8.2.1. U.S. Congestive Heart Failure Drugs Market
8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. Distribution Channel breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Congestive Heart Failure Drugs Market
8.3. Europe Congestive Heart Failure Drugs Market Snapshot
8.3.1. U.K. Congestive Heart Failure Drugs Market
8.3.2. Germany Congestive Heart Failure Drugs Market
8.3.3. France Congestive Heart Failure Drugs Market
8.3.4. Spain Congestive Heart Failure Drugs Market
8.3.5. Italy Congestive Heart Failure Drugs Market
8.3.6. Rest of Europe Congestive Heart Failure Drugs Market
8.4. Asia-Pacific Congestive Heart Failure Drugs Market Snapshot
8.4.1. China Congestive Heart Failure Drugs Market
8.4.2. India Congestive Heart Failure Drugs Market
8.4.3. Japan Congestive Heart Failure Drugs Market
8.4.4. Australia Congestive Heart Failure Drugs Market
8.4.5. South Korea Congestive Heart Failure Drugs Market
8.4.6. Rest of Asia Pacific Congestive Heart Failure Drugs Market
8.5. Latin America Congestive Heart Failure Drugs Market Snapshot
8.5.1. Brazil Congestive Heart Failure Drugs Market
8.5.2. Mexico Congestive Heart Failure Drugs Market
8.5.3. Rest of Latin America Congestive Heart Failure Drugs Market
8.6. Rest of The World Congestive Heart Failure Drugs Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Bayer AG
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Novartis AG
9.2.3. Merck & Co., Inc.
9.2.4. AstraZeneca
9.2.5. Bristol-Myers Squibb Company
9.2.6. Amgen Inc.
9.2.7. Boehringer Ingelheim International GmbH
9.2.8. Pfizer, Inc.
9.2.9. Johnson & Johnson Services, Inc.
9.2.10. Otsuka Pharmaceutical Co., Ltd.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now